These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16556264)

  • 1. Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I.
    Cuesta AM; Suárez E; Larsen M; Jensen KB; Sanz L; Compte M; Kristensen P; Alvarez-Vallina L
    Immunology; 2006 Apr; 117(4):502-6. PubMed ID: 16556264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.
    Ye J; Chen GS; Song HP; Li ZS; Huang YY; Qu P; Sun YJ; Zhang XM; Sui YF
    Cancer Immunol Immunother; 2004 Sep; 53(9):825-34. PubMed ID: 15127237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.
    Ma JH; Sui YF; Ye J; Huang YY; Li ZS; Chen GS; Qu P; Song HP; Zhang XM
    Cancer Immunol Immunother; 2005 Sep; 54(9):907-14. PubMed ID: 15756604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chemical adjuvants on DNA vaccination.
    Jin H; Li Y; Ma Z; Zhang F; Xie Q; Gu D; Wang B
    Vaccine; 2004 Jul; 22(21-22):2925-35. PubMed ID: 15246629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
    Marshall DJ; Rudnick KA; McCarthy SG; Mateo LR; Harris MC; McCauley C; Snyder LA
    Vaccine; 2006 Jan; 24(3):244-53. PubMed ID: 16135392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
    Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
    Stevenson FK; Rice J; Ottensmeier CH; Thirdborough SM; Zhu D
    Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.
    Yan J; Liu X; Wang Y; Jiang X; Liu H; Wang M; Zhu X; Wu M; Tien P
    J Gene Med; 2007 Feb; 9(2):107-21. PubMed ID: 17256801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
    Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW
    Nat Biotechnol; 1999 Mar; 17(3):253-8. PubMed ID: 10096292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth.
    Liang PH; Zhang KQ; Xu GL; Li YF; Wang LF; Nie ZL; Ye J; Wu G; Ge CG; Jin FS
    Cancer Immunol Immunother; 2010 Jan; 59(1):93-101. PubMed ID: 19543726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer.
    Williams BB; Wall M; Miao RY; Williams B; Bertoncello I; Kershaw MH; Mantamadiotis T; Haber M; Norris MD; Gautam A; Darcy PK; Ramsay RG
    Cancer Immunol Immunother; 2008 Nov; 57(11):1635-45. PubMed ID: 18386000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGbeta by DNA immunization.
    Guan QD; Wang Y; Chu YW; Wang LX; Ni J; Guo Q; Xiong SD
    Cancer Immunol Immunother; 2007 Jun; 56(6):875-84. PubMed ID: 17086422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3d enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus.
    Tong T; Fan H; Tan Y; Xiao S; Ling J; Chen H; Guo A
    Biochem Biophys Res Commun; 2006 Sep; 347(4):845-51. PubMed ID: 16857165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen.
    Ali S; Mulryan K; Taher T; Stern PL
    Cancer Immunol Immunother; 2007 Feb; 56(2):165-80. PubMed ID: 16758205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.